Clinical Trials

The University of Virginia Cancer Center frequently opens new clinical trials, offering your patients the latest investigational treatments. For a complete list of active trials and study coordinator contact information, visit our newly launched Find a Clinical Trial website.

If you have patients who may be eligible to participate in a clinical trial, please email cancerclinicaltrials@virginia.edu.

 

 

 

New Trials Available at UVA

Acute Myeloid Leukemia (IRB-HSR #19366)

A Randomized, Double-Blind Phase 3 Study of Vadastuximab Talirine (SGN-CD33A) Versus Placebo in Combination with Azacitidine or Decitabine in the Treatment of Older Patients with Newly Diagnosed Acute Myeloid Leukemia  (NCT02785900)

Primary Investigator: Michael Keng
Clincal Research Coordinator: Amelia Hodson

Myelodysplastic Syndrome (IRB-HSR #19703)

A Phase 3 International, Randomized, Controlled Study of Rigosertib Versus Physician¿s Choice of Treatment in Patients with Myelodysplastic Syndrome After Failure of a Hypomethylating Agent (NCT02562443)

Primary Investigator: Michael Keng
Clincal Research Coordinator: Amelia Hodson

Lymphoma (IRB-HSR #19675)

A Randomized Double-Blind Phase III Study of Ibrutinib During and Following Autologous Stem Cell Transplantation Versus Placebo in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma of the Activated B-cell Subtype

Primary Investigator: Karen Ballen
Clinical Research Coordinator: Kristen Johnson

Neuroblastoma (IRB-HSR #19031)

A Phase I/II Study for the Treatment of Neuroblastoma and GD2-Positive Tumors with Activated T Cells Armed with OKT3 X Humanized 3F8 Bispecific Antibodies (GD2Bi)  (NCT02173093) 

Primary Investigator: Daniel Lee
Clinical Research Coordinator: Candace Hudspeth